Capstone Holding Corp. (CAPS) NASDAQ
0.39
+0.0806(+26.40%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.39
+0.0806(+26.40%)
Currency In USD
Address
1275 West Washington Street
Alsip, IL 60803
United States of America (the)
Phone
602-286-5520
Sector
Basic Materials
Industry
Construction Materials
Employees
36
First IPO Date
January 28, 1993
| Name | Title | Pay | Year Born |
| Matthew E. Lipman | Chief Executive Officer, Secretary & Director | 206,851 | 1979 |
| Kevin Grotke | President & Chief Executive Officer of TotalStone, LLC | 329,766 | 1973 |
| Edward Schultz | Chief Financial Officer | 266,568 | 1985 |
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.